Trial Profile

External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone in Leber's Hereditary Optic Neuropathy (LHON)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

18 Apr 2024 Results (n=196) assessing the long-term efficacy of idebenone in the treatment of Leber hereditary optic neuropathy ,presented at the 76th Annual Meeting of the American Academy of Neurology 2024
08 Mar 2024 This trial has been completed in Italy according to European Clinical Trials Database record.
28 Jun 2022 Results reporting long-term clinical treatment benefit presented at the 8th Congress of the European Academy of Neurology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com